Targeting of human renal tumor-derived endothelial cells with peptides obtained by phage display

Journal of Molecular Medicine

Volumn 85, Issue 8, 2007, Pages 897-906

  Bussolati, Benedetta ^a   Grange, Cristina ^a   Tei, Lorenzo ^b   Deregibus, Maria Chiara ^a   Ercolani, Mauro ^c   Aime, Silvio ^a   Camussi, Giovanni ^a,d  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c Tecnobiomedica SpA   (Italy)

^d MOLINETTE HOSPITAL   (Italy)

Author keywords

Angiogenesis; Angiogenic therapy; Peptides; Phage display; Renal carcinoma

Indexed keywords

CYCLOPEPTIDE; PEPTIDE; PEPTIDE BB1; PEPTIDE LIBRARY; RIBOSOME INACTIVATING PROTEIN; SAPORIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CIRCULATION; COMBINATION CHEMOTHERAPY; CONJUGATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CARCINOMA; MONOTHERAPY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PHAGE DISPLAY; PROTEIN BINDING; SCID MOUSE; TARGET CELL; TUMOR VASCULARIZATION;

EID: 34447512451     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-007-0184-3     Document Type: Article

References (40)

1. Trepel M, Arap W, Pasqualini R (2002) In vivo phage display and vascular heterogeneity: implications for targeted medicine. Curr Opin Chem Biol 6:399-404
2. Arap W, Kolonin MG, Trepel M, Lahdenranta J, Cardo-Vila M, Giordano RJ, Mintz PJ, Ardelt PU, Yao VJ, Vidal CI, Chen L, Flamm A, Valtanen H, Weavind LM, Hicks ME, Pollock RE, Botz GH, Bucana CD, Koivunen E, Cahill D, Troncoso P, Baggerly KA, Pentz RD, Do KA, Logothetis CJ, Pasqualini R (2002) Steps toward mapping the human vasculature by phage display. Nat Med 8:121-127
3. Garlanda C, Dejana E (1997) Heterogeneity of endothelial cells. Specific markers. Arterioscler Thromb Vasc Biol 17:1193-1202
4. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW (2000) Genes expressed in human tumor endothelium. Science 289:1197-1202
5. Bussolati B, Deambrosis I, Russo S, Deregibus MC, Camussi G (2003) Altered angiogenesis and survival in endothelial cells derived from renal carcinoma. FASEB J 17:1159-1161
6. Hida K, Hida Y, Amin DN, Flint AF, Panigrahy D, Morton CC, Klagsbrun M (2004) Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res 64:8249-8255
7. Grange C, Bussolati B, Bruno S, Fonsato V, Sapino A, Camussi G (2006) Isolation and characterization of human breast tumor-derived endothelial cells. Oncol Rep 15:381-386
8. Pasqualini R, Arap W, McDonald DM (2002) Probing the structural and molecular diversity of tumor vasculature. Trends Mol Med 8:563-571
9. Burrows FJ, Thorpe PE (1994) Vascular targeting-a new approach to the therapy of solid tumors. Pharmacol Ther 64:155-174
10. Arap W, Pasqualini R, Ruoslahti E (1998) Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279:377-380
11. Rafii S, Avecilla ST, Jin DK (2003) Tumor vasculature address book: identification of stage-specific tumor vessel zip codes by phage display. Cancer Cell 4:331-333
12. Cooke SP, Boxer GM, Lawrence L, Pedley RB, Spencer DIR, Begent RHJ, Chester KA (2001) A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complex. Cancer Res 61:3653-3659
13. Yasukawa T, Kimura H, Tabata Y, Miyamoto H, Honda Y, Ikada Y, Ogura Y (2000) Active drug targeting with immunoconjugates to choroidal neovascularization. Curr Eye Res 21:952-961
14. Kamizuru H, Kimura H, Yasukawa T, Tabata Y, Honda Y, Ogura Y (2001) Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat. Invest Ophthalmol Vis Sci 42:2664-2672
15. Ellerby HM, Arap W, Ellerby LM, Kain R, Andrusiak R, Rio GD, Krajewski S, Lombardo CR, Rao R, Ruoslahti E, Bredesen DE, Pasqualini R (1999) Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med 5:1032-1038
16. Curnis F, Arrigoni G, Sacchi A, Fischetti L, Arap W, Pasqualini R, Corti A (2002) Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Cancer Res 62:867-874
17. Pasqualini R, Koivunen E, Ruoslahti E (1997) Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol 15:542-546
18. Burg MA, Pasqualini R, Arap W, Ruoslahti E, Stallcup WB (1999) NG2 proteoglycan-binding peptides target tumor neovasculature. Cancer Res 59:2869-2874
19. Halin C, Rondini S, Nilsson F, Berndt A, Kosmehl H, Zardi L, Neri D (2002) Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature. Nat Biotechnol 20:264-269
20. Li Z, Zhao R, Wu X, Sun Y, Yao M, Li J, Xu Y, Gu J (2005) Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. FASEB J 19:1978-1985
21. Zhi M, Wu KC, Dong L, Hao ZM, Deng TZ, Hong L, Liang SH, Zhao PT, Qiao TD, Wang Y, Xu X, Fan DM (2004) Characterization of a specific phage-displayed peptide binding to vasculature of human gastric cancer. Cancer Biol Ther 3:1232-1235
22. Liang S, Lin T, Ding J, Pan Y, Dang D, Guo C, Zhi M, Zhao P, Sun L, Hong L, Shi Y, Yao L, Liu J, Wu K, Fan D (2006) Screening and identification of vascular-endothelial-cell-specific binding peptide in gastric cancer. J Mol Med 84:764-773
23. Oh Y, Mohiuddin I, Sun Y, Putnam JB Jr, Hong WK, Arap W, Pasqualini R (2005) Phenotypic diversity of the lung vasculature in experimental models of metastases. Chest 128:596S-600S
24. Lee L, Buckley C, Blades MC, Panayi G, George AJ, Pitzalis C (2002) Identification of synovium-specific homing peptides by in vivo phage display selection. Arthritis Rheum 46:2109-2120
25. Fonsato V, Buttiglieri S, Deregibus MC, Puntorieri V, Bussolati B, Camussi G (2006) Expression of Pax2 in human renal tumor-derived endothelial cells sustains apoptosis resistance and angiogenesis. Am J Pathol 168:706-713
26. Bussolati B, Grange C, Bruno S, Buttiglieri S, Deregibus MC, Tei L, Aime S, Camussi G (2006) Neural-cell adhesion molecule (NCAM) expression by immature and tumor-derived endothelial cells favors cell organization into capillary-like structures. Exp Cell Res 312:913-924
27. Bussolati B, Assenzio B, Deregibus MC, Camussi G (2006) The proangiogenic phenotype of human tumor-derived endothelial cells depends on thrombospondin-1 downregulation via phosphatidylinositol 3-kinase/Akt pathway. J Mol Med 84:852-863
28. Geninatti Crich S, Bussolati B, Tei L, Grange C, Esposito G, Lanzardo S, Camussi G, Aime S (2006) MR-visualization of Tumor Angiogenesis by targeting NCAM with the highly sensitive Gd-loaded Apoferritin probe. Cancer Res 66:9196-201
29. Biancone L, Stamenkovic I, Cantaluppi V, Boccellino M, De Martino A, Bussolino F, Camussi G (1999) Expression of L-selectin ligands by transformed endothelial cells enhances T cell-mediated rejection. J Immunol 162:5263-5269
30. Line BR, Mitra A, Nan A, Ghandehari H (2005) Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates. J Nucl Med 46:1552-1560
31. Hajitou A, Pasqualini R, Arap W (2006) Vascular targeting: recent advances and therapeutic perspectives. Trends Cardiovasc Med 16:80-88
32. Kerbel RS, Yu J, Tran J, Man S, Viloria-Petit A, Klement G, Coomber BL, Rak J (2001) Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches. Cancer Metastasis Rev 20:79-86
33. Bai F, Liang J, Wang J, Shi Y, Zhang K, Liang S, Hong L, Zhai H, Lu Y, Han Y, Yin F, Wu K, Fan D (2006) Inhibitory effects of a specific phage-displayed peptide on high peritoneal metastasis of gastric cancer. J Mol Med 85:169-180
34. Ellerby HM, Arap W Ellerby LM (1999) Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med 5:1032-1038
35. Fahr A, Muller K, Nahde T, Muller R, Brusselbach S (2002) A new colloidal lipidic system for gene therapy. J Liposome Res 12:37-44
36. Beer AJ, Haubner R, Sarbia M, Goebel M, Luderschmidt S, Grosu AL, Schnell O, Niemeyer M, Kessler H, Wester HJ, Weber WA, Schwaiger M (2006) Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man. Clin Cancer Res 12:3942-3949
37. Nicklin SA, White SJ, Watkins SJ, Hawkins RE, Baker AH (2000) Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display. Circulation 102:231-237
38. Nicklin SA, Buening H, Dishart KL, de Alwis M, Girod A, Hacker U, Thrasher AJ, Ali RR, Hallek M, Baker AH (2001) Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells. Molec Ther 4:174-181
39. White SJ, Nicklin SA, Buning H, Brosnan MJ, Leike K, Papadakis ED, Hallek M, Baker AH (2004) Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors. Circulation 109:513-519
40. Hajitou A, Trepel M, Lilley CE, Soghomonyan S, Alauddin MM, Marini FC 3rd, Restel BH, Ozawa MG, Moya CA, Rangel R, Sun Y, Zaoui K, Schmidt M, von Kalle C, Weitzman MD, Gelovani JG, Pasqualini R, Arap W (2006) A hybrid vector for ligand-directed tumor targeting and molecular imaging. Cell 125:385-398